Why is Sun Pharma.Inds. falling/rising?

As of 09-Sep, Sun Pharmaceutical Industries Ltd is experiencing a price increase, with its current price at Rs 1,595.10, reflecting a rise of Rs 13.5 or 0.85%. The stock is currently 2.51% away from its 52-week low of Rs 1,555, and its performance today is in line with the sector. However, it is important to note that the stock is trading higher than its 5-day moving averages but lower than its 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, there has been a significant decline in investor participation, with delivery volume dropping by 66.84% compared to the 5-day average. Despite these challenges, the company maintains strong long-term fundamentals, including a low debt-to-equity ratio and a healthy return on equity, which supports its valuation.
In the broader market context, Sun Pharmaceutical's short-term return over the past week is +1.95%, outperforming the Sensex, which has increased by 1.18%. However, the stock has underperformed the benchmark over the year-to-date period, with a decline of 15.36% compared to the Sensex's gain of 3.79%. The company's high institutional holdings at 36.75% indicate confidence from larger investors, which may provide some stability amid the stock's recent volatility. Overall, while the stock shows positive short-term movement, its long-term performance remains a concern, particularly given its year-to-date decline.